{"id":"W4211175126","doi":"10.1016/s0140-6736(19)31894-x","title":"Acute liver failure","year":2019,"lang":"en","type":"review","venue":"The Lancet","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":809,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Cancer Institute; Genentech; Novo Nordisk; Sanofi; University of South Carolina; Southwestern Medical Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; Mallinckrodt Pharmaceuticals; U.S. Food and Drug Administration; Bristol-Myers Squibb","keywords":"Medicine; Liver failure; Liver transplantation; Cirrhosis; Liver injury; Liver disease; Chronic liver disease; Internal medicine; Intensive care medicine; Viral hepatitis; Autoimmune hepatitis; Gastroenterology; Hepatitis; Transplantation","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}